# Automated ELISA analyzers

Walk-away microplate processors that automate the full ELISA workflow — sample and reagent dispensing, incubation, washing and photometric reading — for clinical diagnostics, blood-donor screening and biopharma potency/immunogenicity testing, replacing manual multi-step plate handling with a closed, standardized instrument run.

Source: https://en.bioecon.ru/technology/automated-elisa-analyzers/
Updated: 2026-08-18



## Overview and value chain

Markers: [EC: US FDA CLIA + IVDR (EU) 2017/746 for automated immunoassay analyzer classification | OECD: Bio-pharmaceuticals | Regulator: FDA (USA), EMA (EU), NMPA (China)]

Automated ELISA analyzers integrate every step of the enzyme-linked immunosorbent assay
workflow — sample dilution, reagent and substrate dispensing, timed incubation, plate
washing and photometric absorbance reading — into a single walk-away instrument run,
replacing a manual process that otherwise demands a technician's continuous attention
across a multi-hour protocol. The category spans clinical diagnostics laboratories running
infectious-disease and autoimmune panels, blood-establishment donor-screening labs, and
biopharma QC labs running potency, immunogenicity or anti-drug-antibody assays on the same
underlying microplate chemistry. Instruments differ mainly in throughput architecture and
degree of closure: some process one plate at a time through a fully enclosed cabinet with
integrated washing and reading, while others use a modular liquid-handling deck that can
be reconfigured across different assay protocols. The shared value proposition across all
formats is the same — standardized, operator-independent timing at every wash and
incubation step removes the largest source of inter-run variability in manual ELISA,
directly improving assay reproducibility.

The key directions of automated ELISA analysis are:
1. **Closed, integrated ELISA workstations (Closed Workstations):** fully enclosed
   cabinet instruments that carry a microplate through the entire dispense-incubate-wash-
   read cycle without user intervention, the standard for high-volume clinical and
   blood-screening labs.
2. **Modular liquid-handling ELISA automation (Modular Automation):** deck-based systems
   that automate plate handling and reagent dispensing but retain flexibility to
   reconfigure across different assay protocols and plate formats.
3. **Random-access and continuous-loading systems (Random Access):** platforms that
   accept new sample racks mid-run rather than requiring a full batch to complete first,
   maximizing daily throughput in high-volume labs.
4. **Walk-away QC/potency assay automation (Biopharma QC Automation):** ELISA automation
   adapted specifically for GxP-regulated biopharma potency, immunogenicity and
   anti-drug-antibody testing, with 21 CFR Part 11-compliant audit trails.

### Sectoral value chain

```
[Sample + reagents] ──> [Automated dispensing] ──> [Incubation & washing cycles] ──> [Photometric reading]
                                                                  │
                                                          (result calculation)
                                                                  │
                                                                  ▼
[Diagnostic/QC report] <─── [Software: standard-curve fitting, cutoff determination]
```

### Value chain levels

| Level | Description | Key inputs/outputs |
|:---|:---|:---|
| **Sample and reagent loading** | Patient samples, controls, and assay-specific reagents are loaded onto the instrument's deck or carousel. | **In:** raw samples, reagent kits, controls. **Out:** loaded instrument ready to run. |
| **Automated dispensing** | Robotic pipetting dispenses diluted sample, conjugate and substrate into microplate wells per the assay protocol. | **In:** loaded samples/reagents. **Out:** dispensed microplate. |
| **Incubation and washing** | The plate incubates at controlled temperature for defined periods, with automated washing between each reagent addition step. | **In:** dispensed microplate. **Out:** washed, developed microplate. |
| **Photometric reading** | An integrated plate reader measures absorbance at the assay's specified wavelength for each well. | **In:** developed microplate. **Out:** raw absorbance values per well. |
| **Software: result calculation** | Standard-curve fitting or cutoff-based algorithms convert raw absorbance into a quantitative or qualitative (positive/negative) result. | **In:** raw absorbance data. **Out:** per-sample quantitative value or qualitative call. |
| **Reporting** | Results are formatted into a diagnostic report or a GxP-compliant QC record. | **In:** calculated results. **Out:** diagnostic/QC report, LIS/LIMS-compatible data export. |

Cross-cutting technologies of the sector:
- **Barcode-driven sample tracking:** automated readers scan sample and reagent barcodes
  to eliminate manual transcription error across the multi-step ELISA protocol.
- **Multi-wavelength photometric detection:** dual-wavelength absorbance reading corrects
  for plate-bottom optical artifacts, improving result precision versus single-wavelength
  reading.
- **LIS/LIMS bidirectional connectivity:** newer instruments increasingly integrate
  directly with laboratory information systems for order download and automated result
  upload, cutting manual data entry.

---

## US

The US hosts a long-standing dedicated ELISA-automation specialist, positioned across
clinical, research and blood-screening laboratories of varying scale.

### dedicated ELISA processing automation, next-generation walk-away platforms, clinical/research lab deployment
- **DYNEX Technologies:** the DS2 Elite, introduced as the next generation of the
  established DS2 automated ELISA processing platform, is positioned to elevate
  laboratory performance for fully automated ELISA processing across laboratories and
  research clinics of all sizes.

---

## CN

Autobio Diagnostics is a confirmed China-headquartered vendor in this category, one of
the few EQP-kind screens this session to clear with a domestic instrument maker rather
than an import-only market.

### domestic automated-ELISA manufacturing, public-tender-documented deployment, IVD-registered instruments
- **Autobio Diagnostics (Zhengzhou):** a major Chinese in-vitro-diagnostics manufacturer,
  confirmed through government procurement tender records for automated ELISA workstation
  maintenance service and device-registration documentation for its automated
  immunoassay instrument line, evidencing a real, deployed domestic installed base.
- **Screening note:** evidence for this entity came primarily from Chinese government
  procurement tender listings and a device-registration record rather than the vendor's
  own marketing pages, so specification claims are kept general rather than citing exact
  performance numbers.

---

## EU

Italy and Spain both host established diagnostics manufacturers whose automated ELISA
platforms serve clinical and blood-screening laboratories across Europe and beyond.

### microtiter-plate full-process automation, blood-establishment donor-screening platforms, clinical immunoassay analyzers
- **DiaSorin (Italy):** the ETI-MAX 3000 fully automated microplate analyzer performs the
  complete ELISA sample-processing workflow on a single closed instrument, an established
  platform still actively traded on the secondary clinical-equipment market.
- **Grifols (Spain):** the Triturus immunoassay analyzer automates ELISA-format testing,
  positioned within Grifols's broader blood-and-plasma diagnostics portfolio alongside
  its immunohematology sample-processing systems.

---

## Leading companies and research institutes

| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|:---|:---|:---|:---|:---|
| **DYNEX Technologies** | 🇺🇸 USA | *DS2, DS2 Elite* | Fully automated closed ELISA processing for labs of all sizes | Commercial |
| **Grifols** | 🇪🇸 Spain | *Triturus* | Automated immunoassay analyzer within a broader blood/plasma diagnostics portfolio | Commercial, public (NASDAQ:GRFS) |
| **Autobio Diagnostics** | 🇨🇳 China | *Automated ELISA workstation line* | Domestic manufacturing, publicly tendered maintenance/deployment | Commercial, public (SZSE:603658) |
| **DiaSorin** | 🇮🇹 Italy | *ETI-MAX 3000* | Fully automated closed microplate analyzer, complete ELISA workflow | Commercial |

---

## Tech stack and innovations

The stack layers robotic liquid handling, timed incubation/wash cycles and photometric
detection on a common result-calculation software backbone, with the choice between
closed and modular architectures driven by throughput needs and assay-protocol
flexibility.

1. **Closed-cabinet full-process automation:**
   - An integrated instrument carries the microplate through dispensing, incubation,
     washing and reading without operator intervention, minimizing hands-on time and
     inter-operator variability.
   - Suited to high-volume clinical and blood-screening labs running standardized assay
     panels repeatedly.
2. **Modular liquid-handling deck automation:**
   - A reconfigurable pipetting deck automates dispensing and washing while retaining
     flexibility to accommodate different plate formats and assay protocols.
   - Better suited to research or reference labs running varied, less-standardized assay
     menus than a single dedicated clinical panel.
3. **Barcode-driven tracking and LIS/LIMS integration:**
   - Automated barcode scanning of samples and reagents throughout the run eliminates
     manual transcription steps that are a common source of ELISA workflow error.
   - Direct LIS/LIMS connectivity for order download and result upload reduces manual
     data entry and supports audit-trail completeness in regulated environments.

---

## Value chains and production pipelines

### Industrial pipeline of an automated ELISA diagnostic/QC run (CLIA / IVDR)

```
┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Sample/reagent loading  │ ───> │ 2. Automated dispensing     │
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Photometric reading     │ <─── │ 3. Incubation & washing     │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Result calculation      │ ───> │ 6. Diagnostic/QC report    │
└───────────────────────────┘      └───────────────────────────┘
```

#### Stage 1: Sample and reagent loading
Patient samples, controls and assay-specific reagent kits are loaded onto the
instrument's deck or carousel, with barcode scanning confirming correct sample and
reagent identification.

#### Stage 2: Automated dispensing
Robotic pipetting dispenses diluted sample, enzyme-conjugated antibody and substrate into
microplate wells according to the loaded assay protocol.

#### Stage 3: Incubation and washing
The plate incubates at controlled temperature for defined periods specific to each assay
step, with automated washing cycles removing unbound reagent between additions.

#### Stage 4: Photometric reading
An integrated plate reader measures absorbance at the assay's specified wavelength (or
dual wavelengths for optical-artifact correction) for every well on the plate.

#### Stage 5: Result calculation
Software fits a standard curve or applies a cutoff-based algorithm to convert raw
absorbance values into a quantitative concentration or a qualitative positive/negative
call for each sample.

#### Stage 6: Diagnostic or QC report
Results are compiled into a diagnostic report for clinical use or a GxP-compliant QC
record for biopharma potency/immunogenicity testing, with LIS/LIMS-compatible data
export.

---

